|
||
Company Profile
Accuro Biologics is a contract research services company created to provide a new option for those seeking to outsource their needs in; antibody and protein engineering, mammalian cell line development and immunogenicity profiling. The company mission is to provide simple and flexible access to its specialist services. Value to clients is delivered through emphasis on adherence to timelines, budget and high quality science. The company was established in 2005 to serve the pharmaceutical, biotechnology and wider research community. The company operates from its own fully equipped laboratories within the Aberdeen Science and Technology Park, Aberdeen, UK. Through careful provision of specialised technologies as well an on-going commitment to customer satisfaction, Accuro Biologics has demonstrated to its clients that it is a reliable partner for the biopharmaceutical industry. Accuro Biologics comprises a highly experienced laboratory and management team who bring over 30 years experience in the contract research sector. The team has worked on over 40 therapeutic antibody candidates for a variety of sponsors, and collectively amassed a significant track record of delivery and success. This includes working on antibodies that have advanced into clinical development. Antibodies and other proteins have been engineered using a variety of immunogenicity evaluation strategies, including DeImmunisation® technology, of which members of our team are co-inventors. We seek to make our capabilities as widely available as possible and will remain as flexible with our business terms as we are with our laboratory projects. Accuro Biologics does not add to recognised royalty burdens and all rights to the project remain with the sponsor. |
||
DeImmunisation® is a registered trademark of Biovation Ltd |